Abstract:Nonischemic dilated cardiomyopathy is a common form of heart muscle disease in which genetic factors play a critical etiological role. In this regard, both rare disease‐causing mutations and common disease‐susceptible variants, in the Bcl‐2–associated athanogene 3 ( BAG3 ) gene have been reported, highlighting the critical role of BAG3 in cardiomyocytes and in the development of dilated cardiomyopathy. The phenotypic effects of the BAG3 mutations help investigators understand the structure and function of the BAG3 gene. Indeed, we report herein that all of the known pathogenic/likely pathogenic variants affect at least 1 of 3 protein functional domains, ie, the WW domain, the second IPV (Ile‐Pro‐Val) domain, or the BAG domain, whereas none of the missense nontruncating pathogenic/likely pathogenic variants affect the proline‐rich repeat (PXXP) domain. A common variant, p.Cys151Arg, associated with reduced susceptibility to dilated cardiomyopathy demonstrated a significant difference in allele frequencies among diverse human populations, suggesting evolutionary selective pressure. As BAG3 ‐related therapies for heart failure move from the laboratory to the clinic, the ability to provide precision medicine will depend in large part on having a thorough understanding of the potential effects of both common and uncommon genetic variants on these target proteins. The current review article provides a roadmap that investigators can utilize to determine the potential interactions between a patient's genotype, their phenotype, and their response to therapeutic interventions with both gene delivery and small molecules. Nonstandard Abbreviations and Acronyms ACMG American College of Medical Genetics and Genomics B/LB benign/likely benign BAG3 Bcl‐2–associated athanogene 3 CAPZB capping actin protein of muscle Z‐line subunit beta DCM dilated cardiomyopathy eQTL expression quantitative trait locus gnomAD Genome Aggregation Database GTEx Genotype‐Tissue Expression Hsc70 heat shock cognate Hsp70 70 kilo‐dalton heat shock protein IPV Ile‐Pro‐Val LAMP‐2 lysosomal associated membrane protein 2 LTCC L‐type voltage‐gated calcium channel Cav1.2 LD linkage disequilibrium NF‐κB nuclear factor kappa B P/LP pathogenic/likely pathogenic PDZGEF2 PDZ domain containing guanine nucleotide exchange factor 2 PPCM peripartum cardiomyopathy PXXP proline‐rich repeat SH3 Src homology 3 sHsps small heat shock proteins SIFT Sorting Intolerant From Tolerant VUS variant of uncertain significance Cardiomyopathies are a heterogeneous group of diseases of cardiac muscle 1 that include dilated, hypertrophic, restrictive, constrictive and arrhythmogenic right ventricular cardiomyopathies. 2 Dilated cardiomyopathies (DCMs) have been historically separated into those that are secondary to ischemic heart disease (ischemic DCM) and those that are nonischemic, with ischemic DCM being somewhat more common. Genetic variants were first shown to be etiologic in the development of hypertrophic cardiomyopathy 3 , 4 and novel therapies have been developed, using gene therapy 5 or small molecules. 6 By contrast, the cause of DCM has remained more obscure. Recent studies have shown convincingly that both heritable and sporadic genetic variants play a -Abstract Truncated-

Role of BAG3 protein interactions in cardiomyopathies

The Role of BAG3 Protein Interactions in Cardiomyopathies

The Role of BAG3 in Health and Disease: A "magic BAG of Tricks".

BAG3: Nature’s Quintessential Multi-Functional Protein Functions as a Ubiquitous Intra-Cellular Glue

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Functional analysis of a common BAG3 allele associated with protection from heart failure

Bcl2-associated Athanogene 3 Interactome Analysis Reveals a New Role in Modulating Proteasome Activity

Inhibition of HSC70 Alleviates Hypertrophic Cardiomyopathy Pathology in Human Induced Pluripotent Stem Cell‐derived Cardiomyocytes with a MYBPC3 Mutation

HSC70-JNK-BAG3 complex is critical for cardiomyocyte protection of BAG3 through its PXXP and BAG structural domains

Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease

Abstract P2112: Mechanism Of Bag3's Degradation Of Tgfbr2 In Cardiac Fibroblasts

BAG3 Pro209 mutants associated with myopathy and neuropathy relocate chaperones of the CASA-complex to aggresomes

Bag3 Regulates Mitochondrial Function and the Inflammasome Through Canonical and Noncanonical Pathways in the Heart

Genetics of BAG3: A Paradigm for Developing Precision Therapies for Dilated Cardiomyopathies

Evidence for the impact of BAG3 on electrophysiological activity of primary culture of neonatal cardiomyocytes

Inhibition of autophagy prevents cardiac dysfunction at early stages of cardiomyopathy in Bag3-deficient hearts

Different Roles Of Bag3 In Cardiac Physiological Hypertrophy And Pathological Remodeling

Abstract P1007: Cardiac Fibroblast BAG3 Controls TGFBR2 Signaling And Contributes To Engineered Cardiac Tissue Function.

The Role of the Multifunctional BAG3 Protein in Cellular Protein Quality Control and in Disease

Novel BAG3 Variants in African American Patients With Cardiomyopathy: Reduced β-Adrenergic Responsiveness in Excitation–Contraction

Overexpression of human BAG3P209L in mice causes restrictive cardiomyopathy